Especially, METTL13 can mediate the methylation of eEF1A at the N terminus and lysine 55 (eEF1AK55me2), and eEF1AK55me2 is increased in pancreatic and lung cancers and associated with poor clinical outcomes [23, 24]. The gene discussed is METTL13; the disease is lung carcinoma.